BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in BioLineRx Ltd. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- 0 vs. Q3 2024
- Shares held
- 2.01M
- −492.5K (−19.7%) vs. Q3 2024
- Total value
- $435.9K
- −$907.8K (−67.6%) vs. Q3 2024
- New holders
- 10
- 6 more added
- Sold out
- 10
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $206.7K |
| Q1 2026 | 13 | $45.2K |
| Q4 2025 | 14 | $135.6K |
| Q3 2025 | 14 | $104.3K |
| Q2 2025 | 17 | $302.1K |
| Q1 2025 | 12 | $28.0K |
| Q4 2024 | 32 | $435.9K |
| Q3 2024 | 32 | $1.34M |
| Q2 2024 | 31 | $2.42M |
| Q1 2024 | 28 | $1.47M |
| Q4 2023 | 29 | $1.75M |
| Q3 2023 | 29 | $2.46M |
| Q2 2023 | 26 | $1.97M |
| Q1 2023 | 20 | $2.91M |
| Q4 2022 | 18 | $3.37M |
| Q3 2022 | 28 | $10.3M |
| Q2 2022 | 28 | $1.36M |
| Q1 2022 | 26 | $1.99M |
| Q4 2021 | 30 | $5.09M |
| Q3 2021 | 30 | $6.69M |
| Q2 2021 | 30 | $4.01M |
| Q1 2021 | 29 | $13.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding BioLineRx Ltd.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tradewinds Capital Management, LLC | 200 | $43 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,206 | $258 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 3,104 | $664 | 0.00% | +3,104 | New |
| GWM Advisors LLC | 4,300 | $920 | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 4,800 | $1.01K | 0.00% | +300+6.7% | Added |
| Wells Fargo & Company | 5,535 | $1.18K | 0.00% | −29,500−84.2% | Reduced |
| UBS Group AG | 9,196 | $1.97K | 0.00% | +8,212+834.6% | Added |
| Neville Rodie & Shaw Inc | 10,000 | $2.00K | 0.00% | +10,000 | New |
| Hibernia Wealth Partners, LLC | 10,000 | $2.14K | 0.00% | +10,000 | New |
| Wealth Enhancement Advisory Services, LLC | 10,500 | $2.25K | 0.00% | 00.0% | Unchanged |
| Weaver Consulting Group | 11,000 | $2.35K | 0.00% | −18,745−63.0% | Reduced |
| Qube Research & Technologies Ltd | 11,935 | $2.54K | 0.00% | −1,100−8.4% | Reduced |
| Nemes Rush Group LLC | 12,000 | $2.57K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 12,982 | $2.78K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 15,314 | $3.25K | 0.00% | +15,314 | New |
| Royal Bank of Canada | 20,200 | $4.00K | 0.00% | +20,200 | New |
| Captrust Financial Advisors | 20,064 | $4.29K | 0.00% | +3,892+24.1% | Added |
| Watts Gwilliam & Co., LLC | 34,000 | $5.44K | 0.00% | +34,000 | New |
| Citigroup Inc | 31,337 | $6.66K | 0.00% | +31,337 | New |
| Rathbone Brothers plc | 31,666 | $6.78K | 0.00% | −8,154−20.5% | Reduced |
| Two Sigma Securities, LLC | 35,310 | $7.56K | 0.00% | +35,310 | New |
| Geode Capital Management, LLC | 39,993 | $8.50K | 0.00% | 00.0% | Unchanged |
| Gradient Investments LLC | 41,400 | $8.86K | 0.00% | +11,400+38.0% | Added |
| Rhumbline Advisers | 42,961 | $9.14K | 0.00% | +10,350+31.7% | Added |
| Orin Green Financial, LLC | – | $10.9K | 0.00% | – | – |
| BNP Paribas Arbitrage, SA | 57,340 | $12.3K | 0.00% | +57,340 | New |
| Morgan Stanley | 79,102 | $16.9K | 0.00% | −118,435−60.0% | Reduced |
| Susquehanna International Group, LLP | 87,215 | $18.5K | 0.00% | +69,183+383.7% | Added |
| LPL Financial LLC | 92,000 | $19.7K | 0.00% | 00.0% | Unchanged |
| Atria Wealth Solutions, Inc. | 94,133 | $20.1K | 0.00% | 00.0% | Unchanged |
| Values First Advisors, Inc. | 166,449 | $35.6K | 0.02% | −31,067−15.7% | Reduced |
| Highbridge Capital Management LLC | 1,010,012 | $214.6K | 0.01% | +1,010,012 | New |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −866,495−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −239,186−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −157,215−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −133,974−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −80,158−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −44,135−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,326−100.0% | Sold out |
| Cutter & CO Brokerage, Inc. | 0 | $0 | 0.00% | −16,667−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −13,250−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |